Literature DB >> 16639719

Enzymes involved in the bioconversion of ester-based prodrugs.

Bianca M Liederer1, Ronald T Borchardt.   

Abstract

Enzymes are essential for the activation of many prodrugs. In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biology and biochemistry. Most of these enzymes fall into the category of hydrolytic enzymes. However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here. Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochemical and structural features of the prodrugs, will be discussed. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639719     DOI: 10.1002/jps.20542

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  79 in total

1.  Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine.

Authors:  Ping Li; Chun-Liu Zhu; Xin-Xin Zhang; Li Gan; Hong-Zhen Yu; Yong Gan
Journal:  Lipids       Date:  2010-06-08       Impact factor: 1.880

2.  Monoclonal antibodies to human butyrylcholinesterase reactive with butyrylcholinesterase in animal plasma.

Authors:  Hong Peng; Stephen Brimijoin; Anna Hrabovska; Eric Krejci; Thomas A Blake; Rudolph C Johnson; Patrick Masson; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2015-11-14       Impact factor: 5.192

3.  Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs.

Authors:  Christine L Clouser; Laurent Bonnac; Louis M Mansky; Steven E Patterson
Journal:  Antivir Chem Chemother       Date:  2014-12-16

Review 4.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 5.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

6.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

7.  Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.

Authors:  Jiang Li; Shao-Feng Xu; Ying Peng; Nan Feng; Ling Wang; Xiao-Liang Wang
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

8.  Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.

Authors:  Valerie J Winton; Claudia Aldrich; Laura L Kiessling
Journal:  ACS Infect Dis       Date:  2016-06-29       Impact factor: 5.084

9.  Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity.

Authors:  Jonathan C Barnes; Peter M Bruno; Hung V-T Nguyen; Longyan Liao; Jenny Liu; Michael T Hemann; Jeremiah A Johnson
Journal:  J Am Chem Soc       Date:  2016-09-14       Impact factor: 15.419

10.  Undesired versus designed enzymatic cleavage of linkers for liver targeting.

Authors:  Srinivas R Chirapu; Jonathan N Bauman; Heather Eng; Theunis C Goosen; Timothy J Strelevitz; Subhash C Sinha; Robert L Dow; M G Finn
Journal:  Bioorg Med Chem Lett       Date:  2014-01-08       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.